BTK-NF-κB signaling induces PRMT5 transcription in activated DLBCL cells while BCR downstream PI3K-AKT-MYC signaling up-regulates PRMT5 expression in DLBCL cells. This evidence concerns the gene NFKB1 and diffuse large B-cell lymphoma.